Explore 3 Stock Ideas & Industry Insights Download Free Report

MACH7 Technologies Ltd

Company price
0.26 AUD 0.00(0%)
Last update at 2026-11-06T03:57:00Z
VOLUME
4591
Market Cap
61.10M

Momentum Score

…

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. Mach7 Technologies Limited was founded in 2007 and is headquartered in Melbourne, Australia.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.26
Low
0.26
High
52 Week Price Range
0.21
Low
0.69
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

MACH7 Technologies Ltd provides enterprise imaging and medical data management software for hospitals and healthcare networks to ingest, store and distribute diagnostic images and related clinical information. Long-term growth drivers include healthcare digitization, migration to cloud-native enterprise imaging platforms and rising demand for interoperability and AI-enabled workflows, which could support recurring software and services revenue. The company appears positioned as a specialist vendor in a niche segment with potential to replace legacy systems and capture share as institutions modernize imaging infrastructure.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.26
Dividend Yield
-
Revenue TTM
27.95M
Revenue Per Share
0.12
Gross Profit TTM
6.06M
Debt / Equity
0.00
ROE
-22.28%
Net Debt
-19.84M
ROCE
-21.37%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -9.44M -7.96M -9.75M -6.66M -6.33M
Net income -8.93M -6.20M -7.97M -1.05M -4.17M
Selling general administrative - 4.70M 26.96M 27.40M 23.81M
Selling and marketing expenses - 0.85M 0.82M 0.76M 0.69M
Gross profit -1.89M 8.38M -6.42M 29.06M 26.12M
Reconciled depreciation - - 7.25M 8.68M 9.08M
Ebit -7.72M -7.98M -22.34M -17.17M -6.28M
Ebitda -1.18M -7.06M -15.09M -8.49M 2.80M
Depreciation and amortization 6.54M 0.91M 7.25M 8.68M 9.08M
Operating income -7.72M -8.42M -10.09M -7.38M -7.04M
Other operating expenses 35.63M 33.17M 39.20M 6.90M 7.03M
Interest expense 0.07M 0.12M 0.06M 0.05M 0.06M
Tax provision - -1.76M -1.78M -5.61M -2.17M
Interest income - 0.29M 0.89M 0.71M 0.70M
Net interest income - - 0.82M 0.33M -0.03M
Income tax expense -0.51M 1.76M -1.78M -5.61M -2.17M
Total revenue 27.91M 33.79M 17.24M 30.05M 27.08M
Total operating expenses 5.83M 7.77M 5.88M 37.43M 34.12M
Cost of revenue 29.80M 25.40M 23.66M 0.99M 0.96M
Total other income expense net -1.72M 0.46M 12.58M 10.18M 9.20M
Net income from continuing ops - - -7.97M -1.05M -4.17M
Net income applicable to common shares - -6.20M -7.97M -1.05M -4.17M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 50.50M 64.21M 73.03M 82.31M 78.92M
Intangible assets 11.77M 18.34M - 31.11M 39.01M
Other current assets 0.74M 1.83M 0.92M 4.16M 4.04M
Total liab 15.93M 18.63M 21.17M 22.82M 20.55M
Total stockholder equity 34.56M 45.58M 51.86M 59.48M 58.38M
Other current liab 1.19M 13.10M 2.46M 2.66M 2.44M
Common stock 114.02M 114.00M 116.24M 115.70M 115.30M
Capital stock - - - 115.70M 115.30M
Retained earnings -82.82M -75.01M -71.01M -63.53M -63.50M
Other liab - - - 7.00M 9.02M
Good will 3.91M 4.28M 4.19M 4.35M 4.30M
Other assets - - - 4.95M 1.34M
Cash 19.92M 23.07M 26.18M 23.39M 25.75M
Cash and equivalents - - - 16.08M 18.32M
Total current liabilities 14.38M 14.41M 15.09M 14.83M 10.39M
Current deferred revenue 11.69M - 11.63M 11.22M 7.03M
Net debt -19.84M -21.95M -24.91M -22.19M -24.42M
Short term debt 0.07M 0.22M 0.18M 0.21M 0.19M
Short long term debt total 0.08M 1.12M 1.27M 1.20M 1.33M
Other stockholder equity - - - -52.17M -51.80M
Property plant equipment - - - 2.00M 2.07M
Total current assets 26.44M 30.28M 33.27M 34.89M 32.20M
Net tangible assets - - - 24.02M 15.06M
Net receivables 5.78M 5.38M 6.17M 6.71M 2.00M
Inventory - - - 0.63M 0.42M
Accounts payable 1.44M 1.09M 0.82M 0.74M 0.72M
Accumulated other comprehensive income 3.36M 6.59M 6.62M 7.31M 6.58M
Non currrent assets other 1.53M 5.00M 25.02M 5.80M 0.76M
Non current assets total 24.06M 33.93M 39.76M 47.42M 46.72M
Capital lease obligations - - - 1.20M 1.33M
Long term debt total - - - 0.99M 1.14M
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.39M -0.36M -0.44M
Change to liabilities - - - 4.42M 2.97M
Total cashflows from investing activities -0.92M -1.70M -0.39M -0.36M -0.44M
Net borrowings - - - -0.25M -0.41M
Total cash from financing activities -0.16M -2.43M -0.03M -0.07M 0.55M
Change to operating activities - - - -5.45M -0.55M
Net income -8.93M -6.20M -7.97M -1.05M -4.17M
Change in cash -3.15M -3.11M 2.78M -2.35M 24.85M
Begin period cash flow 23.07M 26.18M 23.39M 25.75M 0.90M
End period cash flow 19.92M 23.07M 26.18M 23.39M 25.75M
Total cash from operating activities -1.26M 0.87M 3.45M -2.61M 6.37M
Issuance of capital stock - - 0.19M 0.19M 0.96M
Depreciation 6.54M 7.24M 7.25M 1.17M 1.31M
Other cashflows from investing activities - -0.94M -0.24M - 0.00M
Change to inventory - - - 1.03M -2.42M
Change to account receivables 0.40M 1.08M 3.13M -4.63M 0.08M
Sale purchase of stock -0.00M -2.24M - 0.19M 0.96M
Other cashflows from financing activities -0.18M - -0.22M -0.25M -0.41M
Change to netincome - - - -4.59M -1.03M
Capital expenditures 0.07M 0.76M 0.15M 0.36M 0.44M
Change in working capital 0.80M 0.88M 4.22M -4.63M 0.08M
Stock based compensation - 1.11M 1.27M 1.08M 1.70M
Other non cash items 0.32M -2.16M -1.32M -2.74M 9.23M
Free cash flow -1.33M 0.11M 3.30M -2.97M 5.94M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
M7T
MACH7 Technologies Ltd
-
-%
0.26 - 11.15 2.19 1.77 2.53 41.71
PME
Pro Medicus Ltd
-3.10
1.49%
205.13 81.98 106.38 83.13 43.70 74.38 95.34
4DX
4DMEDICAL Ltd
-0.13
5.39%
2.28 - - 205.57 8.53 170.03 -7.29
CGS
Cogstate Ltd
-0.09
2.66%
3.29 33.80 27.86 9.59 6.95 6.35 19.27
AYA
ARTRYA Ltd
-
-%
3.50 - - 20505.14 7.00 16927.51 0.33

Profile*

MACH7 Technologies Ltd

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, a zero-footprint viewer that allows medical professionals to remotely access patients' medical images; vendor-neutral archive (VNA), a vendor agnostic data management solution, which includes administration tools that allow for the storage, access, retrieval, and viewing of images across a healthcare network. Mach7 Technologies Limited was founded in 2007 and is headquartered in Melbourne, Australia.

385 Bourke Street, Melbourne, VIC, Australia, 3000

61 3 9692 7222

Name Title Year Born
Mr. Michael Lampron CEO, MD & Director NA
Mr. Steven Parkes Global Chief Financial Officer NA
Rebecca Thompson Head of Investor Relations NA
Mr. Bob Tranchida VP of Marketing NA
Mr. David Madaffri Exec. VP NA
Ms. Veronique Morgan-Smith Company Sec. NA
Mr. David Madaffri Chief Operating Officer NA
Francoise Dixon Head of Investor Relations NA
Mr. Bob Tranchida Vice President of Marketing NA
Ms. Dyan O'Herne Chief Financial Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…